Join Now

Afternoon Symposium 11 - Updated Role of Tolvaptan in Heart Failure Management

Friday, October 22nd 2021 (13:00 – 14:05)


Will the use of tolvaptan help clinicians during the whole decongestion process? And if yes, when should we consider adding tolvaptan? If you'd like to know the answer, join this session to know how to properly deliver the use of tolvaptan in decongestion process


Time Topics
13:00 - 13:15 The Importance of Early Decongestive Treatment in Acute Heart Failure (Triwedya Indra Dewi, MD)
13:15 - 13:30 The Advantage of Vasopressin V2-Receptor Antagonist in Heart Failure Outpatient Setting (Rarsari Soerarso, MD)
13:30 - 14:00 Discussion

will be updated soon
Chairperson : Syarif Hidayat Soeriasaputra, MD
Panelist : Vebiona Kartini Prima Putri, MD
  Lita Dwi Suryani, MD
Speaker : Triwedya Indra Dewi, MD
  Rarsari Soerarso, MD